ADMA Biologics Valuation: Underpriced by 63.2%

ADMA Biologics' stock price is undervalued by 63.2% according to a Discounted Cash Flow analysis, with an estimated intrinsic value per share of $44.82 compared to the current price of $16.49. The 3-year and 5-year returns are large at roughly 3x and around 5x respectively. The stock has had mixed momentum with a 1% gain over the last week, an 8.5% decline over the last month, and a 7.8% decline year to date.